New skin treatment enters first human tests for eczema
NCT ID NCT07488065
Summary
This early-stage study aims to test the safety and side effects of an experimental injection called SKB575. It will involve 90 participants, including healthy adults and people with moderate-to-severe atopic dermatitis (eczema). Researchers will monitor how the body processes the drug and look for early signs that it might help reduce eczema symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huashan Hospital Affiliated to Fudan University
Shanghai, 200040, China
-
Huashan Hospital Affiliated to Fudan University
Shanghai, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.